Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Arthi Venkatesan"'
Autor:
Harini Muralidharan, Arthi Venkatesan, Rishitha Venati, Indrani Devi Dhanasekaran, Teshini Suthahar, Abrar Ahmed, Arushi Salhotra, Bijisha Baburaj Nair, Mohana Krishnan, Muhasaparur Ganesan Rajanandh
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 6, Iss , Pp 100142- (2022)
Background: Health care professionals (HCPs) have been using drugs and poison information centre (DIC) less frequently in recent years. The purpose of this study was to identify the barriers that inhibit HCPs from using the DIC service in a tertiary
Externí odkaz:
https://doaj.org/article/28e062ef09544775b61e3be23316628f
Publikováno v:
Borneo Journal of Pharmacy, Vol 2, Iss 2, Pp 71-81 (2019)
Ebola viral disease (EVD) is a deadly infectious hemorrhagic viral fever caused by the Ebola virus with a high mortality rate. Until date, there is no effective drug or vaccination available to combat this condition. This study focuses on designing a
Externí odkaz:
https://doaj.org/article/61a5047a3f574a869678926b0e5a882d
Autor:
Jyoti Kumari, Ankita Mathur, A Rajeshwari, Arthi Venkatesan, Satyavati S, Mrudula Pulimi, Natarajan Chandrasekaran, R Nagarajan, Amitava Mukherjee
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134796 (2015)
The impact of pH and ionic strength on the mobility (individual and co-transport) and deposition kinetics of TiO2 and ZnO NPs in porous media was systematically investigated in this study. Packed column experiments were performed over a series of env
Externí odkaz:
https://doaj.org/article/2cb62e3e39d84bcca6ec027b833ab8ef
Autor:
Sudharsana Sundarrajan, Arthi Venkatesan, Udhaya Kumar S, Mohanraj Gopikrishnan, Iftikhar Aslam Tayubi, M Aditya, Gowrishankar Bychapur Siddaiah, C. George Priya Doss, Hatem Zayed
Publikováno v:
Metabolic Brain Disease.
Alzheimer disease (AD) is a leading cause of dementia in elderly patients who continue to live between 3 and 11 years of diagnosis. A steep rise in AD incidents is observed in the elderly population in East-Asian countries. The disease progresses thr
Autor:
Arthi Venkatesan, Anantha Krishnan Dhanabalan, Selvakumar Rajendran, Shyamala Gowri Shanmugasundharam, Krishnasamy Gunasekaran, J. Febin Prabhu Dass
Publikováno v:
Journal of Cellular Biochemistry. 123:1366-1380
Hepatitis C is an infectious disease that leads to acute and chronic liver illnesses. Currently, there are no effective vaccines against this deadly virus. Direct acting antiviral (DAA) drugs are given in the combination with ribavirin and pegylated
Introduction: Rickettsia is vector-borne causing Rickettsial infections with high mortality. Currently, no vaccines are available for the prevention of rickettsioses. The study aims to identify B- and T- cell epitopes to peptides derived from TolC pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef7498bbcbc58a4eb53cf2a9102e2dcc
https://doi.org/10.21203/rs.3.rs-1454911/v1
https://doi.org/10.21203/rs.3.rs-1454911/v1
Publikováno v:
Current Enzyme Inhibition. 16:162-171
Background: Struvite/infection stone is one of the major clinical burdens in urinary tract infections that is caused by the ureolytic behavior of pathogenic bacteria. Objective: The current strategy for treating infective stones is mostly antibiotic
Publikováno v:
Borneo Journal of Pharmacy, Vol 2, Iss 2, Pp 71-81 (2019)
Ebola viral disease (EVD) is a deadly infectious hemorrhagic viral fever caused by the Ebola virus with a high mortality rate. Until date, there is no effective drug or vaccination available to combat this condition. This study focuses on designing a
Autor:
Pratichi Singh, Parasuraman Padmanabhan, Balázs Gulyás, Arthi Venkatesan, Febin Prabhu Dass J
Publikováno v:
Journal of Cellular Biochemistry. 121:534-544
Hepatitis C virus (HCV) infection is among the leading causes of hepatocellular carcinoma and liver cirrhosis globally, with a high economic burden. The disease progression is well established, but less is known about the spontaneous HCV infection cl
Autor:
Arthi Venkatesan, J. Febin Prabhu Dass
Publikováno v:
Life Sciences. 174:8-14
Background Hepatitis C is an infectious liver disease with high mortality rate which is caused by Hepatitis C virus. Several treatment methods have been applied to combat this deadly virus including interferons, vaccine and direct acting antivirals (